North American Mitochondrial Disease Consortium (NAMDC)


At a Glance
  • Status: Active Consortium
  • Year Launched: 2010
  • Initiating Organization: NIH Rare Disease Clinical Research Network
  • Initiator Type: Government
  • Rare disease
  • Disease focus:
    Mitochondrial Diseases
  • Location: North America

Abstract

Mitochondrial diseases are a challenge because they are probably the most diverse human disorders at every level: clinical, biochemical, and genetic. Although severity varies, by and large these are progressive and often crippling disorders. The North American Mitochondrial Disease Consortium (NAMDC), working closely with United Mitochondrial Disease Foundation (UMDF), is working to address these difficult issues.

Mission

The challenge for the NAMDC is the extraordinary clinical spectrum of mitochondrial diseases, which all too often leads practitioners to either underdiagnose (“What is this complex disorder?”) or overdiagnose (“This disorder is so complex that is must be mitochondrial!”). Yet mitochondrial diseases cause similar metabolic defects and presumably share—albeit to different extents—the same mechanisms. Thus, the availability of a mitochondrial patient registry and consortium will have a powerful impact in multiple ways, as already documented by similar organizations operating in Europe.

NAMDC’s aims are as follows:

Structure & Governance

This consortium is part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research, National Center for Advancing Translational Sciences. The RDCRN is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment, and data sharing. Through the RDCRN consortia, physician scientists and their multidisciplinary teams work together with patient advocacy groups to study more than 200 rare diseases at sites across the nation.

Funding and scientific oversight for the RDCRN are provided by NCATS and 10 National Institutes of Health components: Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Heart, Lung and Blood Institute; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Dental and Craniofacial Research; the National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Mental Health; the National Institute of Neurological Disorders and Stroke; and Office of the Director. In addition, patient advocacy groups provide funds for many of the projects.

Points of Contact

Johnston Grier
NAMDC Central Coordinator
Statistical Analysis Center
Dept. of Biostatistics, Columbia University
722 West 168th St., R614
New York, NY 10032
phone: (212) 342-3671
email: namdc@columbia.edu

Sponsors & Partners

Baylor College of Medicine

Case Western Reserve University

Children’s Hospital Medical Center of Akron

Children’s Hospital of Pittsburgh

Children’s National Medical Center

Cleveland Clinic

Columbia University Medical Center

Lucile Packard Children’s Hospital

Massachusetts General Hospital

Mayo Clinic, Rochester

McMaster University

Seattle Children’s Hospital and Regional Medical Center

The Children’s Hospital of Philadelphia

University of California San Diego

University of Colorado

University of Florida College of Medicine


Last Updated: 04/15/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.